Partnership with Dubai London Clinics & Hospitals

AI SummaryClose X

Oxford BioDynamics Plc has partnered with Dubai London Clinics & Hospitals Group to offer its EpiSwitch PSE prostate cancer test across the UAE, marking its first commercial agreement for this test in the Gulf region. The partnership involves collecting patient blood samples at DLCH facilities for processing at OBD's UK laboratory, with the end-to-end clinical workflow having been successfully validated. Both companies will collaborate on market development and clinician engagement, with test volumes expected to increase over time.

Disclaimer*

UK 100